A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
RasCal Therapeutics, Inc.
RasCal Therapeutics, Inc.
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Filamon LTD
University Hospital Heidelberg
Hoosier Cancer Research Network
UMC Utrecht
M.D. Anderson Cancer Center
Thomas Jefferson University
Shanghai Chest Hospital
University of California, Davis
Essen Biotech
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Novartis
Tango Therapeutics, Inc.
University of Nebraska
Adela, Inc
NRG Oncology
NRG Oncology
Eli Lilly and Company
Dysplasia Diagnostics Limited
Var2 Pharmaceuticals
Harvard Medical School (HMS and HSDM)
Stanford University
Mayo Clinic
University of Washington
Black Diamond Therapeutics, Inc.
City of Hope Medical Center
National Cancer Institute (NCI)
Sun Yat-sen University
Dana-Farber Cancer Institute
University of Kentucky
Massive Bio, Inc.
Mayo Clinic
Eli Lilly and Company
National Cancer Institute (NCI)
Virginia Commonwealth University
Maastricht Radiation Oncology
Latin American Cooperative Oncology Group
Sun Yat-sen University
LigaChem Biosciences, Inc.
Aalborg University Hospital
Alpha Biopharma (Jiangsu) Co., Ltd.
Washington University School of Medicine
Institut Cancerologie de l'Ouest
Incyte Corporation
Jonsson Comprehensive Cancer Center
Apollomics Inc.
NRG Oncology